4 hours Cassava Sciences (NASDAQ:SAVA) Upgraded to “Buy” at HC Wainwright MarketBeat
HC Wainwright raised Cassava Sciences from a “neutral” rating to a “buy” rating and set a $116.00 price target for the company in a report on Tuesday.
HC Wainwright raised Cassava Sciences from a “neutral” rating to a “buy” rating and set a $116.00 price target for the company in a report on Tuesday.